Overview
Lobbying Costs
650,000€
Financial year: Jan 2015 - Dec 2015
Lobbyists (Full time equivalent)
1 Fte (3)
Lobbyists with EP accreditation
0
High-level Commission meetings
2
Lobbying Costs over the years
-
Info
AstraZeneca (AZ)
EU Transparency Register
42561875992-94 First registered on 07 Jun 2011
Goals / Remit
AZ is a global research-based biopharmaceutical company headquartered in the UK. Our skills and resources are focused on discovering, developing and marketing medicines for some of the world’s most serious illnesses, including cancer, diabetes, cardiovacular and respiratory disease. We employ over 59 000 people globally, with 15 000 involved in manufacturing, research and development and commercial activites throughout Europe.
Main EU files targeted
Data Protection Regulation
Trade Policy
Pharmacetical Industry Strategy
Pharmaceutical Incentives (IP) and regulation
Health Technology Assessment
Seasonal Infuenza
Personalised Medicine/healthcare systems
Research policy & programmes (IMI)Address
Head Office
1 Francis Crick Avenue
Cambridge Biomedical Campus
Cambridge CB2 0AA
UNITED KINGDOMEU Office
AstraZeneca
Square de Meeus 37
Brussels 1000
BELGIUM -
People
Total lobbyists declared
3
Employment time Lobbyists 50% 1 25% 2 Lobbyists (Full time equivalent)
1
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
0 accreditations were / are live (in bold) for the selected state of 26 Apr 2017
Name Start date End Date Ms Talita GOBBI 23 Mar 2019 01 Apr 2020 Ms Talita GOBBI 22 Sep 2018 23 Mar 2019 Mr Fredrik Moen 06 Aug 2014 04 Aug 2015 Complementary Information
In 2016 1 employee was engaged up to 50% of their time in defined activites, two were engaged up to 25% and two others for 15% of their time. A number of employees spend between 0-10% of their time providing technical and specialist input to relevant Trade Associations
Person in charge of EU relations
Ms Jennifer Shum (Director EU Government Affairs)
Person with legal responsibility
Mr Pascal Soriot (CEO)
-
Categories
Category
II - In-house lobbyists and trade/business/professional associations
Subcategory
Companies & groups
-
Networking
Affiliation
AstraZeneca is a member of the following organisations in Brussels which spend part of their time in defined activities: European Federation of Pharmaceutical Industries and Associations (EFPIA), European Biopharmaceutical Enterprises (EBE), Vaccines Europe (VE) and the European Alliance for Personalised Medicine (EAPM)
Links to these Trade associations are:
http://www.efpia.eu/
http://www.ebe-biopharma.eu/
http://www.vaccineseurope.eu/
http://www.euapm.eu/Member organisations
None
-
Financial Data
Closed financial year
Jan 2015 - Dec 2015
Lobbying costs for closed financial year
650,000€
Other financial info
This estimate is based on a percentage of the salaries of staff spending more than 10% of their time in defined representation to the European institutions, including a percentage of overheads and travel costs.
100% of outsourced costs are included (totaling €64k), plus a proportion of trade association fees as indicated in related guidelines on the Transparency Register (totalling €295k) -
EU Structures
Groups (European Commission)
None
ACC
None
Groups (European Parliament)
None
Communication activities
None
Other activities
None declared
Meetings
Meetings
2 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
-
Date 02 Jul 2019 Location Brussels Subject Reach Cabinet Cabinet of Commissioner Elżbieta Bieńkowska Portfolio Internal Market, Industry, Entrepreneurship and SMEs Attending - Rolf Carsten Bermig (Cabinet member)
-
Date 18 Apr 2018 Location Brussels Subject Patent protection and trade Cabinet Cabinet of Vice-President Cecilia Malmström Portfolio Trade Attending - Nele Eichhorn (Cabinet member)